September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare ...

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science LLC’s (TSI) sequential dual-treatment regimen of low-dose tissue plasminogen activator (tPA) and HisproUK (TSI’s mutant prourokinase [proUK]) in ischemic stroke patients. The study follows a recently completed Phase 1 study that confirmed the safety and tolerability of TSI’s regimen in healthy volunteers (n=26).

While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary artery bypass graft (CABG) surgery compared to vein grafts, it is not known if there are additional benefits with the use of a second artery. This was explored in the ten-year outcomes of the Arterial Revascularisation Trial (ART) presented in a Hot Line Session at the European Society of Cardiology (ESC) Congress 2018, Aug. 25-28 in Munich, Germany.

The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important preparations patients should make before undergoing a computed tomography (CT) scan.